Advertisement

Journal of Clinical Immunology

, Volume 28, Issue 3, pp 232–236 | Cite as

Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis

  • Ö. Ates
  • B. Musellim
  • G. Ongen
  • A. Topal-Sarıkaya
Article

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is an infectious disease in humans killing nearly three million people and eight million cases annually. The cytokines TNF-α and IL-10 have been implicated in the pathogenesis of TB. Certain single nucleotide polymorphisms within the promoter region of the IL10 and TNF genes have been associated with altered levels of circulating IL10 and TNF- α. We analyzed TNF-α (−308 G/A, −238 G/A, −376 G/A) and IL10 (−1,082 G/A, −819 C/T, −592 C/A) polymorphisms in 128 patients with TB and 80 healthy subjects using by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). A significant association was found between TB and −1,082 G allele (Pc: 0.000, O.R 2.22, 95% CI 1.45–3.41). Significant difference was observed in IL10 GCC and ACC haplotypes distribution between TB and control subjects (Pc: 0.000, O.R 2.22, 95% CI 1.45–3.41; Pc: 0.004, O.R 0.53, 95% CI 0.35–0.81). No statistically significant association was found between IL-10 −819 C/T, TNF-α 308 G/A, −238 G/A, −376 G/A polymorphisms, functional TNFα/IL-10 genotypes and TB. Our findings suggest that IL-10 108 2G/A alleles or haplotypes containing these alleles may influence the Th1/Th2 balance and hence may play a role in TB susceptibility and increase risk of developing disease. This polymorphism may be one of the many genetic factors affecting disease outcome.

Keywords

IL- 10 TNF- α tuberculosis polymorphism 

References

  1. 1.
    Raviglione M, Snider D, Kochi A. Global epidemiology of tuberculosis. Mortality and morbidity of a worldwide epidemic. JAMA. 1995;273:220–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Sılva CL, Bonato VLD, Lıma KM, Coelho-Castelo AAM, Faccıolı LH, Sartorı A, et al. Cytotoxic T cells and mycobacteria. FEMS Microbiol Lett. 2001;197:11–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Van Deventer SJH. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med. 2000;26:98–102.CrossRefGoogle Scholar
  4. 4.
    De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209–20.PubMedCrossRefGoogle Scholar
  5. 5.
    Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;146:3445–51.Google Scholar
  6. 6.
    Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martinez-Maza O. Differential regulation of IL-6 gene transcription and expression by IL-4 and Il-10 in human monocytic cell lines. J Immunol. 1996;156:2591–98.PubMedGoogle Scholar
  7. 7.
    Knight J. Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome. Curr Infect Dis Rep. 2001;3:427–39.PubMedCrossRefGoogle Scholar
  8. 8.
    Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verveij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997;349:170–73.PubMedCrossRefGoogle Scholar
  9. 9.
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.PubMedCrossRefGoogle Scholar
  10. 10.
    Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transpl Immunol. 1999;7:127–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Richardson A, Sisay-Joof F, Ackerman H, Usen S, Katundu P, Taylor T, et al. Nucleotide diversity of the TNF gene region in an African village. Genes Immun. 2001;2:343–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis. 2002;186:1463–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Oh JH, Yang CS, Noh YK, Kweon YM, Jung SS, Son JW, Kong SJ, Yoon J, Lee JS, Kım HJ, Park JK, Jo EK, Song CH. Polymorphisms of interleukin-10 and tumour necrosis factor-α genes are associated with newly diagnosed and recurrent pulmonary tuberculosis. Respirology. 2007;12:594–98.PubMedCrossRefGoogle Scholar
  14. 14.
    Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 1998;79:83−9.PubMedCrossRefGoogle Scholar
  15. 15.
    Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codocen R, Madero R, Vazquez JJ, Montiel C. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003;167:970−5.PubMedCrossRefGoogle Scholar
  16. 16.
    Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun. 2005;6:358–63.PubMedCrossRefGoogle Scholar
  17. 17.
    Shın HD, Park BL, Kım YH, Cheong HS, Lee IH, Park SK. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Exp Mol Med. 2005;37(2):128–32.PubMedGoogle Scholar
  18. 18.
    Oral HB, Ferah B, Uzaslan EK, Basturk B, Bekar A, Akalın H, Ege E, Ener B, Goral G. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine 2006;35:6143–7.CrossRefGoogle Scholar
  19. 19.
    Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes Immun. 2000;1:321–24.PubMedCrossRefGoogle Scholar
  20. 20.
    Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumor necrosis-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet. 2000;27:241–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant. 2002;2:560–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Mok CC, Lanchbury JS, Chan DW, Lau SC. Interleukin 10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1090–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW, et al. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-γ genes in the Korean population. Hum Immunol. 2003;64:979–89.PubMedCrossRefGoogle Scholar
  24. 24.
    Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H, et al. Genetic association between interleukin-10 gene promoter region polymorphisms and type I diabetes age-at-onset. Hum Immunol. 2002;63:690–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Kroeger KM, Carville KS, Abraham LJ. The −308 tumour necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997;34:391–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Amirzargar AA, Danesh AA, Khosravi F, Niknam HH, Nikbin B. Cytokines genes polymorphisms in Iranian patients with pulmonary tuberculosis. IJI. 2004;2:125–9.Google Scholar
  27. 27.
    Henao MI, Montes C, París SC, García LF. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis. 2006;86:11–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Vejbaesya S, Chıerakul N, Luangtrakool P, Sermduangprateep C. NRAMP1 and TNF-α polymorphisms and susceptibility to tuberculosis in Thais. Respirology. 2007;12:202–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Oliveıra MM, Sılva JCS, Costa JF, Amım LH, Loredo CCS, Melo H, Queıroz LF, et al. Single Nucleotide Polymorphisms (SNPs) of the TNF-a (−238/−308) gene among TB and non TB patients: susceptibility markers of TB occurrence. Jornal Brasileiro de Pneumologia 2004;30:461–67.Google Scholar
  30. 30.
    Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005;32:219–24.PubMedGoogle Scholar
  31. 31.
    Hill AVS, Ruwende C, McGuire W, Bellamy R, Coleman E, Ali S, Loke H, Corrah T, Snow R, Marsh K, Greenwood B, McAdam KJWP, Whittle HC, Kwiatkowski D. Association of the TNF −238 promoter polymorphism with susceptibility to tuberculosis and malaria in Africa. Hum Immunol. 1996;47:118.CrossRefGoogle Scholar
  32. 32.
    Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C. A genetically determined high setting of TNF-α influences immunological parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol. 2001;62:705–13.PubMedCrossRefGoogle Scholar
  33. 33.
    Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 1999;167:257–74.PubMedCrossRefGoogle Scholar
  34. 34.
    Kindler V, Shappino AP, Grau GE, Pignet PF, Vassali P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989;56:731–40.PubMedCrossRefGoogle Scholar
  35. 35.
    Rojas M, Oliver M, Gros P, Barrera LF, Garcia LF. TNF-a and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J Immunol. 1999;162:6122–31.PubMedGoogle Scholar
  36. 36.
    Gerard C, Bruyns C, Marchant A Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxaemia. J Exp Med. 1993;177:547–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Ö. Ates
    • 1
  • B. Musellim
    • 2
  • G. Ongen
    • 2
  • A. Topal-Sarıkaya
    • 1
  1. 1.Department of Molecular Biology and Genetics, Science FacultyIstanbul UniversityIstanbulTurkey
  2. 2.Chest Disease Department, Cerrahpasa Medical FacultyIstanbul UniversityIstanbulTurkey

Personalised recommendations